Robyn Lynne Ward
Department of Medical Oncology
St. Vincent's Hospital
Sydney
New South Wales
Australia
Name/email consistency: high
- Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified. Ward, R.L., Turner, J., Williams, R., Pekarsky, B., Packham, D., Velickovic, M., Meagher, A., O'Connor, T., Hawkins, N.J. J. Pathol. (2005)
- The CpG island methylator phenotype is not associated with a personal or family history of cancer. Ward, R.L., Williams, R., Law, M., Hawkins, N.J. Cancer Res. (2004)
- Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. Ward, R.L., Cheong, K., Ku, S.L., Meagher, A., O'Connor, T., Hawkins, N.J. J. Clin. Oncol. (2003)
- Medical oncology. Ward, R.L., Hawkins, N.J. Med. J. Aust. (2002)
- Impact of microsatellite testing and mismatch repair protein expression on the clinical interpretation of genetic testing in hereditary non-polyposis colorectal cancer. Ward, R., Meldrum, C., Williams, R., Mokany, E., Scott, R., Turner, J., Hawkins, N., Burgess, B., Groombridge, C., Spigelman, A. J. Cancer Res. Clin. Oncol. (2002)
- Microsatellite instability and the clinicopathological features of sporadic colorectal cancer. Ward, R., Meagher, A., Tomlinson, I., O'Connor, T., Norrie, M., Wu, R., Hawkins, N. Gut (2001)
- Checking the scoreboard: the impact of cancer genetics on clinical practice. Ward, R.L., Hawkins, N.J. Intern. Med. J (2001)
- Factors influencing the detection of mutant K-ras in the serum of patients with colorectal cancer. Ward, R., Sheehan, C., Norrie, M., Applegate, T., Fuery, C., Impey, H., Hawkins, N., Todd, A. Ann. N. Y. Acad. Sci. (2000)
- Phase I clinical trial of the chimeric monoclonal antibody (c30.6) in patients with metastatic colorectal cancer. Ward, R.L., Packham, D., Smythe, A.M., Murray, J., Anderson-Stewart, P., Kitchen, N., Muirhead, R., Phillips, P., Gray, P., Bigg-Wither, G., Prabakaran, K., Freund, J., Fullham, M., Rule, M., Dalley, D., Meagher, A., Hawkins, N.J., Smith, G.M. Clin. Cancer Res. (2000)
- Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples. Ward, R., Hawkins, N., O'Grady, R., Sheehan, C., O'Connor, T., Impey, H., Roberts, N., Fuery, C., Todd, A. Am. J. Pathol. (1998)